Company Pulls Drug for Lou Gehrig's Disease

Biogen ends development after it fails drug trial

By John Johnson,  Newser Staff

Posted Jan 3, 2013 12:08 PM CST

(Newser) – An experimental drug that showed promise of becoming the first effective treatment for Lou Gehrig’s Disease is being pulled by its manufacturer because it performed miserably in a major drug trial. Biogen says its drug, dexpramipexole, did nothing to improve the condition of patients...   Read full story »

Other Sites We Like:   The Street   |   MSN Living   |   PopSugar Tech   |   RealClear   |   24/7 Wall St.   |   Biography   |   Barstool Sports   |   OK!